Study of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal Cancer

NCT00851084 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

268

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Neoplasms
Neoplasm Metastasis

Interventions

DRUG: aflibercept
DRUG: oxaliplatin
DRUG: 5-FU
DRUG: Folinic Acid

Sponsor

Sanofi